Samsara BioCapital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Samsara BioCapital’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,845,948	Closed	-$115M	–	42
2023 Q4	$115M	Hold	1,845,948	–	–	17.85%	2
2023 Q3	$41M	Buy	+1,845,948	New	+$38.8M	12.54%	2

Samsara BioCapital's RYZB Position: Q1 2024 in Review

Samsara BioCapital sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,845,948 shares — an estimated $115M sold.

Samsara BioCapital first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $115M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Samsara BioCapital reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Samsara BioCapital sold 1,845,948 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $115M.
Samsara BioCapital first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Samsara BioCapital's RayzeBio, Inc. Common Stock position peaked at $115M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Samsara BioCapital's 13F filing for Q1 2024, filed 15 May 2024.